In a two-stage dose-response meta-analysis a common functional relationship is applied to each study and an overall curve is obtained by combining study-specific dose-response coefficients. Possible limitations are: 1) a common dose-response model may have a poor fit in some of the studies; 2) combining dose-response coefficients discard information about study-specific exposure range. A pointwise approach for meta-analysis may overcome those limitations by combining predicted relative risks for a fine grid of exposure values based on potentially different doseresponse models.
INTRODUCTION
Dose-response meta-analysis is an increasingly popular statistical technique for combining and contrasting the association between a quantitative exposure on a health outcome. The number of quantitative reviews including an evaluation of the dose-response relation increased from 6 in 2002 to 158 in 2017. The traditional approach consists of a twostage procedure in which the dose-response coefficients are estimated within each study (first stage) and then combined across studies using meta-analysis (second stage) [1, 2] . Alternatively, a one stage approach can be based on a single mixed-effect model for meta-analysis, which has been shown to be equivalent to the two-stage approach [3, 4] .
Both approaches are flexible tools for modeling the dose-response relation under investigation. However, a feature of these models is that the same functional form (e.g. linear, quadratic) is assumed to equally apply to all the studies [5] . This may have important consequences if the estimated dose-response relation has a good fit for only a subset of the studies or if the *Address correspondence to this author at the Department of Public Health Sciences, Karolinska Institutet, 171 65, Solna, Sweden; Tel: +46(0)852482264; E-mail: alessio.crippa@ki.se dose-response model cannot be uniformly specified across studies. The former case may occur, for instance, in a fractional polynomial model where the same power terms are chosen for all the studies [6] . The latter, instead, could happen in a spline model where equally locating the knots across the studies may be difficult because the exposure may vary considerably across studies [7] .
The pooled dose-response curve is typically presented in terms of predicted effects, here referred to as relative risks, for a range of exposure values. All the studies participate to the pooled predictions regardless of their observed exposure distribution. This may be have an impact in meta-analyses where part of the studies considered only a limited exposure range. The pooled relative risk for high exposure values will also be based on those extrapolations.
In 2011 Sauerbrei and Royston [8] proposed a flexible strategy to combine dose-response data for individual patient data (IPD) meta-analysis. The strategy consists of predicting the study-specific relative risks for selected exposure levels in each study using different dose-response models. The predicted relative risks are then combined pointwise by a weighted average to obtain a summary estimate of the dose-response relation. The described approach has the potential to overcome the aforementioned limitations: different dose-response models can be fitted within each study while predicted relative risks can be limited in each study to the observed exposure range and then combined.
Aim of this is paper is to evaluate whether and to what extent the pointwise approach can be used for meta-analysis of aggregated patient data (APD). In Section 2 we describe what are the steps of the pointwise analysis for dose-response meta-analysis. The methodology applied to either individual or aggregated patient data in the Surveillance, Epidemiology, and End Results (SEER) program is presented in Section 3. We also consider potential advantages as compared to the two-stage approach by analyzing aggregated data on the association between milk consumption and all-cause mortality. We conclude with the discussion and final remarks in Section 4.
METHODS
Aggregated dose-response data typically consist of a series of relative risks for a set of exposure comparisons. One category, generally the unexposed one, serves as referent [2] . We first present how to independently estimate the curves and predict relative risks in each study based on aggregated data using both fractional polynomial and spline models. The predicted relative risks are then combined pointwisely across studies by meta-analysis.
Estimation of Study-Specific Curves
Separately for each i-th study, i = 1, …, I, the doseresponse model can be expressed as
where y i and x i are, respectively, the vectors of nonreferent log relative risks and dose levels in the i-th study. The dose-response models are typically expressed as a linear combination of p transformations of the dose. Given the limited number of non-referent dose levels, p < 3 transformations are often adopted. The reported relative risks are not independent since they share a common reference group. Greenland and Longnecker described how to account for the correlations and efficiently estimate a trend from such aggregated data by using weighted least square estimation [9] .
Several alternatives can be chosen to model the dose-response relation under investigation. Fractional polynomials and splines models are two common choices, since many curves can be estimated by using a limited number of dose transformations (p = 2).
A fractional polynomial model is defined as
for each p i1 and p i 2 , combination of predefined values {-2,-1, -0.5, 0, 0.5, 1, 2, 3}. The fractional polynomial with the lowest value of the Akaike's Information Criterion is generally chosen as the best in the predefined set of models [10] .
Splines consist of piecewise polynomials jointly connected over sequentially intervals defined by knots. Restricted cubic splines, in particular, restrict the ends of the curve to be linear [11] . By using three knots
where the "+" notation ( u + = u if u + > 0 and u + = 0 otherwise) has been used.
In both Equation 2 and 3 we used the subscript i for the power terms p and for the knots k to emphasize that they can vary across the study. For instance, the best fitting fractional polynomials may have a different combination of power terms in two studies, as well as different knots in a spline model. This is not possible in the two-stage approach since the ! i needs to refer to (exactly the) same dose transformations in order to be combined by meta-analysis.
Prediction of Study-Specific Log Relative Risks
Once the study-specific curves have been chosen, the predicted log relative risks, ŷ i , and the corresponding variances, v i , can be calculated for a fine grid of exposure values ! x using a suitable value ! x 0 as referent,
with study-specific predictions that can be limited to the observed exposure range with the clear advantage of limiting the impact of extrapolation.
Averaging Dose-Response Predictions
A pointwise strategy derives a pooled curve by combining the study-specific predicted log relative risks instead of combining dose-response coefficients. Differently from the ! i that are specific to the chosen dose transformations, ŷ i refer to ! x dose levels that are common for all the studies, and thus can be properly combined using standard methodology for metaanalysis.
Assuming a random-effects model, the pooled predicted log relative risks ŷ can be estimated as a pointwise weighted average
where the weights are defined as
being the between-studies heterogeneity [12] .
The pooled dose-response curve can be graphically presented as a smooth function of the pooled relative risks for selected exposure values. Similarly, a variety of useful results from the meta-analytic models, such as ! 2 estimates, values of w i and measures of heterogeneity, can also be presented pointwisely either in a graphical or tabular format.
RESULTS
We present two applications of the pointwise approach summarizing the relationships between 1) age and breast cancer survival, and 2) milk consumption and all-cause mortality.
Age and Breast Cancer Survival
The SEER program provides individual data about cancer statistics from several population-based registries in the United States (http://seer.cancer.gov), here treated as independent studies. We are interested in pooling the evidence regarding age as prognostic factor for breast cancer survival, using nine of the SEER registries (5719 cases and 75,249 participants).
Separately for each study we first derived aggregated data by categorizing age in five categories with 47, 57, 65, 73 years as cut-points (i.e. the 20th, 40th, 60th, and 80th percentiles of the overall age distribution). We thus modeled age by including 4 dummy variables using (57, 65] as reference category and adjusting for major confounding variables in 9 separate Cox models, one for each registry. More information about the data, variables considered, and selection criteria can be found in the article by Tai et al. [13] . A snapshot of the data obtained for the first two registries is presented in Table 1 .
We then used fractional polynomials as in Equation 2 to estimate the study-specific curves from the obtained aggregated data. The Akaike's Information Criterion was used to choose, separately in each study, the best fitting model. The corresponding analysis were also performed on individual patient data. The optimal set of power transformations based on APD and IPD are reported in Web Table 1 . In the following step we computed the predicted (log) hazard ratios for a fine grid of age values from 30 to 90 years, using 60 as A graphical comparison of the pooled hazard ratios from the two strategies is presented in Figure 1 . The study-specific curves based on APD predicted more heterogeneous hazard ratios at the extremes of the age distribution. The pooled dose-response curves, however, provided comparable findings, suggesting a U-shaped relation with a minimum at 50 years of age. The hazard ratios of breast cancer were 1.03 (95% CI 0.98, 1.09) at 40 years and 1.25 (95% CI 1.17, 1.32) at 80 years in the IPD analysis. The corresponding estimates were 1.05 (95% CI 0.96, 1.14) and 1.21 (95% CI 1.11, 1.32) in the APD analysis.
Milk and all-Cause Mortality
Let's consider a meta-analysis of APD between milk consumption (ml/day) and mortality based on 14 prospective studies including 70,743 deaths occurred among 367,505 participants [14] .
The exposure range was considerably heterogeneous across studies. Table 2 shows how the assigned exposure scores for milk consumption differed in terms of number of values considered, range definition, and choice of referent.
In case of heterogeneous exposure distribution, choosing common knots is difficult. For instance, the 3 selected knots at the 10th, 50th, and 90th percentiles of the overall distribution (0, 149, and 500 ml/day) were in the exposure range of only 2 studies. As a consequence, problems in the estimation may occur (singularity in the design matrix) and/or fictitious nonlinear curves may be observed in some of the studyspecific analyses.
In the pointwise strategy, instead, knots location can be defined within the singles studies, for example selecting the minimum, median, and maximum of the assigned dose levels ( Table 2) . This avoids problems in the estimation algorithm and has the potential of improving the fit in the individual analyses. Estimation of pooled hazard ratios may also be cumbersome when pooling dose-response coefficients. Let us consider for example two of the studies included in the analysis, presented graphically in the left panel of Figure 2 . When the two exposure distributions were overlapping, saying milk consumption below 350 ml/day, the two approaches provided similar inference (right panel of Figure 2 ). Above 350 ml/day the twostage approach suggests an upward trend mainly driven by extrapolating the results of Dik 2014, whereas the pointwise approach indicates a downward trend based on the only study available (Ness, 2001 ).
We now analyze the dose-response associations arising from all the 14 included studies. In each study, we modeled milk consumption by using restricted cubic splines, where the knots were defined separately in each study. The advantage of the pointwise approach is to visualize and distinguish predicted hazard ratios based on observed data and model-based extrapolations (Figure 3) . Figure 4 plots the pooled hazard ratios and their corresponding confidence intervals comparing the two strategies. It is interesting to note the narrower confidence intervals for the twostage approach's estimates in the upper tail of the exposure distribution (above 500 ml/day) where only 4 out of 14 (30%) studies were available. The pooled hazard ratio of all-cause mortality associated with 700 relative to 150 ml/day was 1.30 (95% CI 0.83, 2.06) for the pointwise, and 1.17 (95% CI 0.98 1.41) for the twostage approach.
The pointwise approach allows the presentation of statistics from the meta-analytical models as a function of the exposure (Figure 5) . Estimates of the betweenstudy heterogeneity, ! 2 , were close to zero for milk consumption less than 300 ml/day and progressively increased for higher values (panel (a)). The weights used in the random-effects meta-analysis suggested a certain degree of homogeneity, with the exception for milk consumption of 100 ml/day, where two studies counted for the 70% of the total weight in the pooled hazard ratio (panel (b)).
Measures of heterogeneity can also be presented graphically. The p-value for the Q statistic is often used to test presence of statistical heterogeneity. The Q test detected significant heterogeneity for milk consumption greater than 100 ml/day (panel (c)). The I 2 confirmed a substantial degrees of heterogeneity for levels of milk consumption higher than 100 ml/day.
DISCUSSION
In this paper we presented a pointwise approach described for dose-response meta-analysis of aggregated data. The strategy consists in combining predicted relative risks arising from different studyspecific dose-response models. We described how to flexibly model the dose-response associations using either fractional polynomials or restricted cubic splines. The pointwise approach allows a better fit of the data within each study and prevent overconfidence in the pooled estimates by taking into account the varying number of data points along the range of the exposure distribution.
Our empirical evaluation of the SEER program based on aggregated data provided very similar results to those based on individual data, which are often considered as the gold standard of systematic review [15] . Collecting and analyzing summarized data has several benefits in terms of reducing time, cost, and number of people involved in pooling the available evidence on a certain exposure-disease association [16] . An alternative explanation for the good agreement may be the fact that individual registries data were uniformly collected, organized, and documented [17] . Published studies, however, can be expected to be more heterogeneous in terms of study populations, available potential confounders, exposure, and outcome definitions [18] . Analysis of aggregated data is inevitably sensitive to how individual data have been summarized. An evaluation of the extent of the heterogeneity of the study-specific curves should be performed before presenting a pooled dose-response association [19] . In the practical examples we addressed this problem by both visually inspecting the individual curves and reporting measures of heterogeneity commonly used in quantitative reviews.
Although the aim of a dose-response meta-analysis is to estimate a curve that equally applies across the studies, forcing a common functional relationship may lower the fit of some individual analyses [5] . One of the advantage of the pointwise approach consists in the flexibility in the modeling individual curves. In a twostage meta-analysis of non-linear relationships, for example, all the studies providing less than two non- referent exposure levels are excluded from the analysis. In the proposed approach, instead, this can be avoided by fitting a linear trend in those studies with just one non-referent exposure level.
Another important advantage of the pointwise strategy is in terms of pooling relative risks, taking into account the exposure range upon which they were estimated. In case of heterogeneous exposure distributions, as in the presented example on milk consumption and all-cause mortality, this feature may have important consequences when deriving the pooled curve. In particular, both point and interval predictions are affected, with the latter being generally narrower and prone to overconfident conclusions.
Finally, numerical and graphical presentation of the pooled results in the pointwise strategy is richer as compared to a two-stage approach. Results from the meta-analytic models can be examined pointwisely for a fine grid of selected exposure values.
CONCLUSION
In conclusion, application of the proposed strategy may improve dose-response meta-analysis of epidemiological studies, particularly in case of heterogeneous exposure distributions. The described methodology is fairly general so that intermediate steps can be adapted to handle specific issues at hand. R code to reproduce results from worked examples is available on GitHub. 
